Forward-looking statement.

This website contains forward-looking statements that involve risks, uncertainties, and assumptions. If the risks or uncertainties materialize or our assumptions prove to be incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact could be deemed forward-looking, including, but not limited to, any expectations regarding investment returns; any projections of financial information; any statements about historical results that may suggest trends for our business; any statements regarding the plans, strategies, and objectives of management for future operations, including our regulatory, preclinical and clinical activities with respect to our Avian Paramyxovirus platform, manufacturing and process development; any statements of expectation or belief regarding future events, potential opportunities, products, markets or market size, technology developments, enforceability of our intellectual property rights or competitive strengths, threats or position within the industry; and any statement or assumptions underlying any of the above-mentioned items.

These statements are based on estimates and information available to us at the time of this website and do not guarantee future performance. Actual results could differ materially from our current expectations as a result of various risks and uncertainties, including, but not limited to, risks associated with: the success, cost, and timing of our research, discovery, product development activities, preclinical studies and clinical trials of our product candidates; our ability to obtain regulatory approval for and to commercialize applications of our Avian Paramyxovirus platform; our ability to establish a commercially-viable manufacturing process and manufacturing infrastructure; regulatory requirements and regulatory developments; the effects of competition and technological advances; our dependence on third-party collaborators and other contractors with respect to our research and development activities, including the conduct of preclinical studies, clinical trials and the commercial manufacture of our products; and our ability to obtain, maintain, and protect intellectual property rights related to our Avian Paramyxovirus platform.

We assume no obligation and do not intend to update any forward-looking statements, or to conform these statements to actual results or to changes in our expectations.